Cloetta (CLA) Q3 2025 earnings summary

Executive summary

• Profitability improved significantly, with EBIT margin reaching 11.9% for the quarter and 11.4% on a rolling 12-month basis, nearing the 2027 target of at least 12%.

• Organic sales growth was 1.3% in the quarter and 2.2% year-to-date, with strong performance in the Nordics and double-digit growth in the US, offset by softness in the rest of Europe.

• Strategic focus remains on core Nordic markets and top super brands, with expansion in the UK, Germany, and North America.

• Major organizational restructuring and efficiency measures have been completed, supporting profitability and future growth.

• Inflation slowed, impacting market dynamics and creating new opportunities.

Financial highlights

• Net sales for the quarter were SEK 2,177 million, with organic growth of 1.3% and a sequential increase of nearly SEK 100 million.

• Adjusted operating profit for Q3 was SEK 259 million (+8.8% year-over-year), with EBIT margin at 11.9%.

• Free cash flow reached SEK 339 million in the quarter, exceeding SEK 500 million year-to-date for the first time.

• Net debt reduced to SEK 1,361 million (down from SEK 1,843 million), with net debt/EBITDA at 1.1x, the lowest ever.

• Profit after tax year-to-date was SEK 558 million; EPS for the period was SEK 0.66 (+46.7%).

Outlook and guidance

• Midterm EBIT margin target of at least 12% by 2027 and long-term adjusted EBIT target of 14% remain in place.

• Organic growth target raised to 3%-4%, with expectations to see results from strategic changes in the coming year.

• Full effect of operating structure changes expected in Q1 2026, with up to 20% of annualized savings realized in H2 2025.

• Dividend policy updated to payout above 50% of profit after taxes.

• Expectation to receive compensation for a Q1 2024 quality incident within the next six months.